CIK 0001055726 · Non-accelerated filer<br>Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330969592
- Phone
- 8584103134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-10 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −5,500 | 5,500 | ||
| 2024-02-28 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Common Stock Option | +69,733 | 69,733 | ||
| 2024-02-28 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Restricted Stock Unit | +55,895 | 55,895 | ||
| 2024-02-28 | Humeau Laurent Chief Scientific Officer | Grant or award · Common Stock Option | +18,750 | 18,750 | ||
| 2024-02-28 | Humeau Laurent Chief Scientific Officer | Grant or award · Restricted Stock Unit | +15,029 | 15,029 | ||
| 2024-02-28 | KIES PETER CFO | Grant or award · Common Stock Option | +18,750 | 18,750 | ||
| 2024-02-28 | KIES PETER CFO | Grant or award · Restricted Stock Unit | +15,029 | 15,029 | ||
| 2024-02-28 | Sumner Michael John Chief Medical Officer | Grant or award · Common Stock Option | +18,750 | 18,750 | ||
| 2024-02-28 | Sumner Michael John Chief Medical Officer | Grant or award · Restricted Stock Unit | +15,029 | 15,029 | ||
| 2024-02-26 | Weiner David B. Director | Option exercise | +972 | 78,399 | ||
| 2024-02-26 | Weiner David B. Director | Option exercise | +972 | 79,371 | ||
| 2024-02-26 | Weiner David B. Director | Option exercise | +972 | 80,343 | ||
| 2024-02-26 | Weiner David B. Director | Option exercise · Restricted Stock Unit | −972 | 0 | ||
| 2024-02-26 | Weiner David B. Director | Option exercise · Restricted Stock Unit | −972 | 972 | ||
| 2024-02-26 | Weiner David B. Director | Option exercise · Restricted Stock Unit | −972 | 1,944 | ||
| 2024-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | +1,878 | 18,387 | ||
| 2024-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −872 | $8.16 | $7K | 17,515 |
| 2024-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | +5,853 | 23,368 | ||
| 2024-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −2,856 | $8.16 | $23K | 20,512 |
| 2024-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −1,878 | 0 |
Page 11 of 17 · 322 trades